Baseline and Dynamic Risk Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy

被引:30
|
作者
Wu, Katherine C. [1 ]
Wongvibulsin, Shannon [2 ,3 ]
Tao, Susumu [1 ]
Ashikaga, Hiroshi [1 ,2 ,3 ]
Stillabower, Michael [5 ]
Dickfeld, Timm M. [6 ]
Marine, Joseph E. [1 ]
Weiss, Robert G. [1 ,4 ]
Tomaselli, Gordon F. [7 ,8 ]
Zeger, Scott L. [9 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[4] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA
[5] Christiana Care Hlth Syst Inc, Newark, DE USA
[6] Univ Maryland, Med Syst, Dept Med, Baltimore, MD 21201 USA
[7] Albert Einstein Coll Med, Bronx, NY USA
[8] Montefiore Med, Bronx, NY USA
[9] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2020年 / 9卷 / 20期
基金
美国国家卫生研究院;
关键词
cardiac magnetic resonance imaging; heart failure; risk stratification; sudden cardiac death; ventricular arrhythmia; VENTRICULAR EJECTION FRACTION; SUDDEN CARDIAC DEATH; HEART-FAILURE; MAGNETIC-RESONANCE; MYOCARDIAL RECOVERY; SURVIVAL; ARRHYTHMIAS; MADIT; IDENTIFY; PATIENT;
D O I
10.1161/JAHA.120.017002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Current approaches fail to separate patients at high versus low risk for ventricular arrhythmias owing to overreliance on a snapshot left ventricular ejection fraction measure. We used statistical machine learning to identify important cardiac imaging and time-varying risk predictors. Methods and Results Three hundred eighty-two cardiomyopathy patients (left ventricular ejection fraction <= 35%) underwent cardiac magnetic resonance before primary prevention implantable cardioverter defibrillator insertion. The primary end point was appropriate implantable cardioverter defibrillator discharge or sudden death. Patient characteristics; serum biomarkers of inflammation, neurohormonal status, and injury; and cardiac magnetic resonance-measured left ventricle and left atrial indices and myocardial scar burden were assessed at baseline. Time-varying covariates comprised interval heart failure hospitalizations and left ventricular ejection fractions. A random forest statistical method for survival, longitudinal, and multivariable outcomes incorporating baseline and time-varying variables was compared with (1) Seattle Heart Failure model scores and (2) random forest survival and Cox regression models incorporating baseline characteristics with and without imaging variables. Age averaged 57 +/- 13 years with 28% women, 66% white, 51% ischemic, and follow-up time of 5.9 +/- 2.3 years. The primary end point (n=75) occurred at 3.3 +/- 2.4 years. Random forest statistical method for survival, longitudinal, and multivariable outcomes with baseline and time-varying predictors had the highest area under the receiver operating curve, median 0.88 (95% CI, 0.75-0.96). Top predictors comprised heart failure hospitalization, left ventricle scar, left ventricle and left atrial volumes, left atrial function, and interleukin-6 level; heart failure accounted for 67% of the variation explained by the prediction, imaging 27%, and interleukin-6 2%. Serial left ventricular ejection fraction was not a significant predictor. Conclusions Hospitalization for heart failure and baseline cardiac metrics substantially improve ventricular arrhythmic risk prediction.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Cardiac implantable defibrillator in primary prevention: predictors of appropriate therapy
    Marta Braga, M.
    Nascimento, H.
    Ribeiro, V.
    Melao, F.
    Oliveira, S. M.
    Vasconcelos, M.
    Dias, P.
    Frutuoso, C.
    Maciel, M. J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 377 - 377
  • [22] Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: Results from the EVADEF cohort study
    Otmani, Akii
    Trinquart, Ludovic
    Marijon, Eloi
    Lavergne, Thomas
    Waintraub, Xavier
    Lepiffier, Antoine
    Chatellier, Gilles
    Le Heuzey, Jean-Yves
    AMERICAN HEART JOURNAL, 2009, 158 (02) : 230 - 237E1
  • [23] Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator
    van Barreveld, M.
    Dijkgraaf, M. G. W.
    Hulleman, M.
    Boersma, L. V. A.
    Delnoy, P. P. H. M.
    Meine, M.
    Tuinenburg, A. E.
    Theuns, D. A. M. J.
    van der Voort, P. H.
    Kimman, G. P.
    Buskens, E.
    Tijssen, J. P. G.
    Bruinsma, N.
    Verstraelen, T. E.
    Zwinderman, A. H.
    van Dessel, P. H. F. M.
    Wilde, A. A. M.
    NETHERLANDS HEART JOURNAL, 2017, 25 (10) : 574 - 580
  • [24] Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator
    M. van Barreveld
    M. G. W. Dijkgraaf
    M. Hulleman
    L. V. A. Boersma
    P. P. H. M. Delnoy
    M. Meine
    A. E. Tuinenburg
    D. A. M. J. Theuns
    P. H. van der Voort
    G. P. Kimman
    E. Buskens
    J. P. G. Tijssen
    N. Bruinsma
    T. E. Verstraelen
    A. H. Zwinderman
    P. H. F. M. van Dessel
    A. A. M. Wilde
    Netherlands Heart Journal, 2017, 25 : 574 - 580
  • [25] Paradox of Appropriate Implantable Cardioverter-Defibrillator Therapy: Saving Lives But Revealing an Increased Mortality Risk
    Aleong, Ryan G.
    Sauer, William H.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (08):
  • [26] Predictors and Proarrhythmic Consequences of Inappropriate Implantable Cardioverter-Defibrillator Therapy
    Tenma, Taro
    Yokoshiki, Hisashi
    Mizukami, Kazuya
    Mitsuyama, Hirofumi
    Watanabe, Masaya
    Sasaki, Ryo
    Maeno, Motoki
    Matsui, Yoshiro
    Tsutsui, Hiroyuki
    CIRCULATION JOURNAL, 2015, 79 (09) : 1920 - U242
  • [27] Predictors of implantable cardioverter defibrillator therapy in patients with nonischemic heart disease
    Rankovic, V
    Karha, J
    Passman, R
    Kadish, AH
    Goldberger, J
    CIRCULATION, 2000, 102 (18) : 396 - 396
  • [28] The role of cardiovascular magnetic resonance in appropriate selection of implantable cardioverter defibrillator therapy
    James, S. Stephanie
    Waterhouse, D.
    Mc Adam, B.
    Foley, D.
    Sheahan, R.
    O' Hanlon, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 326 - 327
  • [29] Appropriate Therapy But Not Inappropriate Shocks Predict Survival in Implantable Cardioverter Defibrillator Patients
    Dichtl, Wolfgang
    Wolber, Thomas
    Paoli, Ursula
    Bruellmann, Simon
    Stuehlinger, Markus
    Berger, Thomas
    Spuller, Karin
    Strasak, Alexander
    Pachinger, Otmar
    Haegeli, Laurent M.
    Duru, Firat
    Hintringer, Florian
    CLINICAL CARDIOLOGY, 2011, 34 (07) : 433 - 436
  • [30] Appropriate therapy but not inappropriate shocks predict survival in implantable cardioverter defibrillator patients
    Dichtl, W.
    Wolber, T.
    Paoli, U.
    Bruellmann, S.
    Stuehlinger, M.
    Berger, T.
    Haegeli, L.
    Duru, F.
    Pachinger, O.
    Hintringer, F.
    EUROPEAN HEART JOURNAL, 2010, 31 : 838 - 838